Shares of Clover Health Corp. (NASDAQ: CLOV) surged by nearly 6% on Thursday, propelled by positive developments related to its Medicare Advantage plans and benchmark rates from the Centers for Medicare & Medicaid Services (CMS).
For the 2025 plan year, CMS awarded Clover Health's Medicare Advantage PPO plans a coveted 4-star quality rating, while its HMO plans received a respectable 3.5-star rating. These high ratings are expected to significantly boost Clover Health's competitiveness and ability to attract and retain Medicare Advantage enrollees, a key driver of growth for the company.
Furthermore, Clover Health announced that its 4-star rating for its PPO contract will lead to a general 5% increase in benchmark payment rates for the 2026 plan year. This increase in benchmark rates, which are used to determine Medicare Advantage plan reimbursements from CMS, is expected to directly translate into higher revenues for the company.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。